"Aztreonam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Descriptor ID |
D001398
|
MeSH Number(s) |
D02.065.589.099.500.044 D02.886.108.500.044 D03.383.411.350.044 D03.633.100.300.500.044
|
Concept/Terms |
Aztreonam- Aztreonam
- Az-threonam
- Az threonam
- Azthreonam
|
Below are MeSH descriptors whose meaning is more general than "Aztreonam".
Below are MeSH descriptors whose meaning is more specific than "Aztreonam".
This graph shows the total number of publications written about "Aztreonam" by people in this website by year, and whether "Aztreonam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 3 | 1 | 4 |
2018 | 3 | 2 | 5 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Aztreonam" by people in Profiles.
-
Successful Treatment of Klebsiella pneumoniae NDM Sepsis and Intestinal Decolonization with Ceftazidime/Avibactam Plus Aztreonam Combination in a Patient with TTP Complicated by SARSCoV-2 Nosocomial Infection. Medicina (Kaunas). 2021 Apr 28; 57(5).
-
[New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation]. Anaesthesist. 2019 11; 68(11):785-800.
-
TEM-184, a Novel TEM-Derived Extended-Spectrum ß-Lactamase with Enhanced Activity against Aztreonam. Antimicrob Agents Chemother. 2018 09; 62(9).
-
Two for the price of one: emerging carbapenemases in a returning traveller to New York City. BMJ Case Rep. 2018 Jul 18; 2018.
-
Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015. Sci Rep. 2018 05 31; 8(1):8468.
-
Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection. J Antimicrob Chemother. 2018 04 01; 73(4):1104-1106.
-
Development and validation of an LC tandem MS assay for the quantification of ß-lactam antibiotics in the sputum of cystic fibrosis patients. J Antimicrob Chemother. 2018 Jan 01; 73(1):95-101.
-
In vitro evaluation of aerosol delivery of aztreonam lysine (AZLI): an adult mechanical ventilation model. Expert Opin Drug Deliv. 2017 12; 14(12):1447-1453.
-
Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome ß-Lactam Resistance Conferred by Metallo-ß-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017 09; 61(9).
-
Targeted Metabolomics Analysis Identifies Intestinal Microbiota-Derived Urinary Biomarkers of Colonization Resistance in Antibiotic-Treated Mice. Antimicrob Agents Chemother. 2017 08; 61(8).